Association of admission aggregate index of systemic inflammation with lower-extremity deep vein thrombosis after severe trauma
- 1Trauma Center, The 960th Hospital of the Joint Logistics Support Force of the Chinese People's Liberation Army, Jinan, Shandong, China.
Abstract
Early identification of patients at risk for lower-extremity deep vein thrombosis (LEDVT) after severe trauma remains difficult. This retrospective cohort study evaluated whether admission aggregate index of systemic inflammation (AISI), derived from platelet, neutrophil, monocyte, and lymphocyte counts, was associated with ultrasound-confirmed in-hospital LEDVT detected before the earlier of discharge or post-injury day 30 and whether it improved risk stratification. Among 223 adults with an Injury Severity Score of 16 or higher and evaluable bilateral lower-extremity ultrasonography, 93 (41.7%) had LEDVT. Each 1-SD increase in log-transformed AISI was associated with LEDVT after adjustment for age, sex, Injury Severity Score, Glasgow Coma Scale score, and shock index (odds ratio [OR], 2.07; 95% CI, 1.47–2.91; P < 0.001) and after additional adjustment for D-dimer, fibrin/fibrinogen degradation products, prothrombin time, activated partial thromboplastin time, and fibrinogen (OR, 1.86; 95% CI, 1.26–2.73; P = 0.002). Adding AISI to clinical variables increased the area under the receiver operating characteristic curve (AUC) from 0.619 to 0.714 (AUC difference, 0.095; bootstrap 95% CI, 0.023 to 0.168; P = 0.009). After coagulation markers were included, the AUC difference was smaller and uncertain (0.018; 95% CI, −0.010 to 0.046; P = 0.166), although the Brier score improved by 0.014 (P = 0.020). For Model 4, bootstrap-corrected and repeated-cross-validation AUCs were 0.797 and 0.790, and calibration slopes were 0.831 and 0.773, respectively. With 93 events and 11 candidate parameters, these internally validated results indicate shrinkage and require prospective external validation; AISI should be interpreted as a complementary admission marker.
Related
- Upper extremity venous thrombosis in hospitalized patients: A prospective epidemiological study
- Role of inflammation in venous thrombosis formation and resolution
- Mechanisms of Carrageenan-Induced Immune Inflammation and Thrombosis: A Narrative Review.
- Association between admission serum potassium and quantitative external lumbar drainage responsiveness in patients with hydrocephalus: a retrospective study
- Association between early post-insertion arterial oxygen tension and documented acute upper-body deep or central venous thrombosis in critically ill adults: A retrospective MIMIC-IV cohort study
BibTeX
@article{sun2026association,
title = {{Association of admission aggregate index of systemic inflammation with lower-extremity deep vein thrombosis after severe trauma}},
author = {Qichang Sun and Donghui Bian},
journal = {PLOS One},
year = {2026},
month = oct,
doi = {10.1371/journal.pone.0360039},
url = {https://doi.org/10.1371/journal.pone.0360039},
note = {CC BY},
}
RIS
TY - JOUR
TI - Association of admission aggregate index of systemic inflammation with lower-extremity deep vein thrombosis after severe trauma
AU - Qichang Sun
AU - Donghui Bian
PY - 2026
DA - 2026/10/21
JO - PLOS One
DO - 10.1371/journal.pone.0360039
UR - https://doi.org/10.1371/journal.pone.0360039
AB - Early identification of patients at risk for lower-extremity deep vein thrombosis (LEDVT) after severe trauma remains difficult. This retrospective cohort study evaluated whether admission aggregate index of systemic inflammation (AISI), derived from platelet, neutrophil, monocyte, and lymphocyte counts, was associated with ultrasound-confirmed in-hospital LEDVT detected before the earlier of discharge or post-injury day 30 and whether it improved risk stratification. Among 223 adults with an Injury Severity Score of 16 or higher and evaluable bilateral lower-extremity ultrasonography, 93 (41.7%) had LEDVT. Each 1-SD increase in log-transformed AISI was associated with LEDVT after adjustment for age, sex, Injury Severity Score, Glasgow Coma Scale score, and shock index (odds ratio [OR], 2.07; 95% CI, 1.47–2.91; P < 0.001) and after additional adjustment for D-dimer, fibrin/fibrinogen degradation products, prothrombin time, activated partial thromboplastin time, and fibrinogen (OR, 1.86; 95% CI, 1.26–2.73; P = 0.002). Adding AISI to clinical variables increased the area under the receiver operating characteristic curve (AUC) from 0.619 to 0.714 (AUC difference, 0.095; bootstrap 95% CI, 0.023 to 0.168; P = 0.009). After coagulation markers were included, the AUC difference was smaller and uncertain (0.018; 95% CI, −0.010 to 0.046; P = 0.166), although the Brier score improved by 0.014 (P = 0.020). For Model 4, bootstrap-corrected and repeated-cross-validation AUCs were 0.797 and 0.790, and calibration slopes were 0.831 and 0.773, respectively. With 93 events and 11 candidate parameters, these internally validated results indicate shrinkage and require prospective external validation; AISI should be interpreted as a complementary admission marker.
SN - 1932-6203
ER -